ProShares Ultra CRCL (CRCA) belongs to the Leveraged Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with CRCA. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to CRCA
CRCA charges 0.95% annually. There are 96 ETFs in the Leveraged Equities category with lower expense ratios, going as low as 0.35%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| WisdomTree Efficient U.S. Plus International Equit... | 0.35% | 43.18M | Mar 2026 | CRCA vs NTSD | |
| Corgi BRKB 2x Daily ETF | 0.45% | — | Jul 2026 | CRCA vs BRKL | |
| ETRACS IFED Invest with the Fed TR Index ETN | 0.45% | 48.07M | Sep 2021 | CRCA vs IFED | |
| Direxion Daily S&P 500 Bull 2X ETF | 0.60% | 260.25M | May 2014 | CRCA vs SPUU | |
| Leverage Shares 2X Long NIO Daily ETF | 0.75% | — | Dec 2025 | CRCA vs NIOG |
Best Risk-Adjusted Alternatives to CRCA
Among 284 ETFs in the Leveraged Equities category with risk / return rank data, the top risk-adjusted alternatives shown here go as high as 98.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| Direxion Daily MU Bull 2X Shares | 98 | 3.86B | Oct 2024 | CRCA vs MUU | |
| GraniteShares 2x Long MU Daily ETF | 98 | 531.06M | Nov 2024 | CRCA vs MULL | |
| Innovator U.S. Equity Accelerated Plus ETF | 98 | 22.69M | Apr 2021 | CRCA vs XTAP | |
| GraniteShares 2x Long INTC Daily ETF | 97 | 282.58M | Feb 2025 | CRCA vs INTW | |
| Innovator Growth Accelerated Plus ETF - April | 97 | 20.37M | Apr 2021 | CRCA vs QTAP |
Top Performing CRCA Alternatives (YTD)
CRCA is at -70.23% YTD. There are 338 ETFs in the Leveraged Equities category with higher YTD returns, going as high as 615.57%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| GraniteShares 2x Long DELL Daily ETF | 615.57% | 101.24M | Feb 2025 | CRCA vs DLLL | |
| Direxion Daily MU Bull 2X Shares | 372.51% | 3.86B | Oct 2024 | CRCA vs MUU | |
| GraniteShares 2x Long MU Daily ETF | 359.36% | 531.06M | Nov 2024 | CRCA vs MULL | |
| Direxion Daily INTC Bull 2X Shares | 259.95% | 63.06M | Nov 2025 | CRCA vs LINT | |
| GraniteShares 2x Long INTC Daily ETF | 259.86% | 282.58M | Feb 2025 | CRCA vs INTW |
Lowest Volatility Alternatives to CRCA
CRCA has 193.78% 1-year volatility. There are 393 ETFs in the Leveraged Equities category with lower 1-year volatility, going as low as 4.93%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Innovator U.S. Equity Accelerated Plus ETF | 4.93% | 22.69M | Apr 2021 | CRCA vs XTAP | |
| Innovator Growth Accelerated Plus ETF - April | 6.61% | 20.37M | Apr 2021 | CRCA vs QTAP | |
| Innovator U.S. Equity Accelerated Plus ETF - July | 7.79% | 13.42M | Jul 2021 | CRCA vs XTJL | |
| Innovator US Equity Accelerated ETF | 10.98% | 69.34M | Apr 2021 | CRCA vs XDSQ | |
| Innovator Growth Accelerated Plus ETF - July | 11.72% | 19.11M | Jul 2021 | CRCA vs QTJL |
Lowest Drawdown Alternatives to CRCA
Among 284 ETFs in the Leveraged Equities category with 1-year drawdown data, the lowest-drawdown alternatives shown here go as shallow as -1.72%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Innovator U.S. Equity Accelerated Plus ETF | -1.72% | 22.69M | Apr 2021 | CRCA vs XTAP | |
| Innovator Growth Accelerated Plus ETF - April | -2.81% | 20.37M | Apr 2021 | CRCA vs QTAP | |
| Innovator U.S. Equity Accelerated Plus ETF - July | -5.12% | 13.42M | Jul 2021 | CRCA vs XTJL | |
| Innovator Growth Accelerated Plus ETF - July | -8.48% | 19.11M | Jul 2021 | CRCA vs QTJL | |
| Innovator US Equity Accelerated ETF | -9.60% | 69.34M | Apr 2021 | CRCA vs XDSQ |
Other ETFs from ProShares
The 10 most viewed ProShares ETFs shown here include TQQQ, QLD, BITO and span 10 categories. AUM among these funds goes as high as $33B.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| ProShares UltraPro QQQ | Leveraged Equities | 36 | 23.06% | 32.83B | Feb 2010 | CRCA vs TQQQ | |
| ProShares Ultra QQQ | Leveraged Equities | 39 | 18.94% | 12.76B | Jun 2006 | CRCA vs QLD | |
| ProShares Bitcoin Strategy ETF | Cryptocurrency | 1 | -29.42% | 1.41B | Oct 2021 | CRCA vs BITO | |
| ProShares UltraPro S&P 500 | Leveraged Equities, S&P 500 | 50 | 21.72% | 5.15B | Jun 2009 | CRCA vs UPRO | |
| ProShares Ultra S&P500 | Leveraged Equities, S&P 500 | 54 | 16.14% | 7.81B | Jun 2006 | CRCA vs SSO | |
| ProShares S&P 500 Dividend Aristocrats ETF | Dividend, S&P 500, Large Cap Value Equities | 47 | 10.84% | 11.68B | Oct 2013 | CRCA vs NOBL | |
| ProShares Ultra Semiconductors | Leveraged Equities, Semiconductors | 52 | 50.25% | 2.47B | Jan 2007 | CRCA vs USD | |
| ProShares UltraPro Short QQQ | Leveraged Equities, Inverse Equities, Nasdaq-100 | 2 | -34.61% | 2.00B | Feb 2010 | CRCA vs SQQQ | |
| ProShares Nasdaq-100 High Income ETF | Nasdaq-100, Derivative Income, Dividend | 44 | 10.08% | 394.37M | Mar 2024 | CRCA vs IQQQ | |
| ProShares Ultra VIX Short-Term Futures ETF | Volatility | 2 | -35.24% | 244.68M | Oct 2011 | CRCA vs UVXY |
Often Compared With CRCA
Investors most often compare CRCA with DFNM, BITU, GRAG. These 20 comparison targets span 10 categories, based on PortfoliosLab usage data.
Compare CRCA with Any Fund or Stock
Compare CRCA with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair CRCA with funds that move differently
ProShares Ultra CRCL alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to CRCA.
Explore CRCA Diversifiers